Key result
CRISPR-Cas9 shows potential to overcome limitations of standard immunosuppression for autoimmune disorders.
Its licence doesn't allow us to show a copy here.
Why the study?
Existing immunosuppressive and immunomodulatory therapies for autoimmune disorders impair immune defenses and predispose to opportunistic diseases, presenting significant limitations and challenges.
Can CRISPR-Cas9 and CRISPR interference technologies address the limitations of existing therapies for autoimmune diseases?
Can CRISPR-Cas9 and CRISPR interference technologies address the limitations of existing therapies for autoimmune diseases?
CRISPR-Cas9 technology represents a potential novel therapeutic approach for autoimmune diseases that may overcome the infection risks associated with current immunosuppressive therapies.
Should not yet change autoimmune therapies; leaves open the need for clinical CRISPR trials.
Autoimmune disorders can be described as inappropriate immune responses directed against self-antigens, which account for substantial healthcare concerns around the world. Immunosuppression or immune modulation are the main therapeutic modalities for autoimmune disorders. These modalities, however, impair the ability of the immune system to fight against infections, thereby predisposing to opportunistic diseases. This review explores existing therapies for autoimmune disorders, highlighting their limitations and challenges. Additionally, it describes the potential of CRISPR-Cas9 technology as a novel therapeutic approach to address these challenges.
No takes yet. Share an insight, caveat, or question.
Khademi et al. (2025) conducted a review in Autoimmune disorders. CRISPR-Cas9 and CRISPR interference technologies vs. Existing therapies (immunosuppression or immune modulation) was evaluated. CRISPR-Cas9 technology offers a potential novel therapeutic approach to address the limitations and challenges of existing immunosuppressive therapies for autoimmune disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: